|Michael J. Fox, Parkinson’s Sufferer|
The Journal of Neuroscience Research reports that the drug lithium has been found to greatly prevent the buildup of the toxic proteins and brain cell loss linked to Parkinson’s disease.
Commonly used to treat bipolar disorder, it has demonstrated a neuroprotective effect in diseases such as Huntington’s disease, Alzheimer’s and amyotrophic lateral sclerosis.æ
Investigators at the Buck Institute for Research have started preclinical studies to determine the proper lithium dosage for humans, and initiate Phase II clinical trials in conjunction with Parkinson’s disease.